Assessment of KM-001 - Safety, Tolerability, and Efficacy in Patients With PPPK1 or PC
Clinical trial NCT05956314 · COMPLETED
Trial details
- NCT number
- NCT05956314
- Sponsor
- Orvida Pharma (formerly Kamari Pharma)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-06
- Primary completion
- 2024-11-07
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.